Meeting
2018 ASCO Annual Meeting
A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy.
Authors
Tanya B. Dorff
City of Hope, Duarte, CA
Tanya B. Dorff , Mahshid Shelechi , Irene Kang , Todd E Morgan , Susan G. Groshen , Sriram Yennu , Agustin A. Garcia , David I. Quinn , Valter Longo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT01802346
Citation
J Clin Oncol 36, 2018 (suppl; abstr TPS10132)
DOI
10.1200/JCO.2018.36.15_suppl.TPS10132
Abstract #
TPS10132
Poster Bd #
116b
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Efficacy and safety of dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: A multicenter, open-label, randomized phase II study.
First Author: Shigeto Maeda
Poster
2021 ASCO Annual Meeting
Phase II trial of perioperative chemotherapy + avelumab in locally advanced gastroesophageal adenocarcinoma: Preliminary results.
First Author: Thierry Alcindor
Poster
2019 ASCO Annual Meeting
Targeting IGF-1/2 with xentuzumab (Xe) plus enzalutamide (En) in metastatic castration-resistant prostate cancer (mCRPC) after progression on docetaxel chemotherapy (DCt) and abiraterone (Abi): Randomized phase II trial results.
First Author: Syed A. Hussain
Poster
2018 Genitourinary Cancers Symposium
Safety and efficacy of abiraterone acetate (AA) in patients aged 75 or more with metastatic castration-resistant prostate cancer (mCRPC) in both pre-chemotherapy or post-chemotherapy settings: Real-life experience from thirteen Italian centers.
First Author: Zuzana Sirotova